Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Figueiredo

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Cell Host & Microbe|June 15, 2011
KAPs off for HIV-1 integrationAnna Figueiredo, Thomas J Hope
Current HIV Research|March 14, 2008
Impact of residues in the nonnucleoside reverse transcriptase inhibitor binding pocket on HIV-1 reverse transcriptase heterodimer stabilityAnna Figueiredo, Shannon Zelina, Nicolas Sluis-Cremer, et al.
Journal of Virology|December 14, 2007
Heat shock perturbs TRIM5alpha restriction of human immunodeficiency virus type 1Jenny L Anderson, Edward M Campbell, Anna Figueiredo, et al.
Plos Pathogens|November 14, 2006
Potent nonnucleoside reverse transcriptase inhibitors target HIV-1 Gag-PolAnna Figueiredo, Katie L Moore, Johnson Mak, et al.
Journal of Virology|August 21, 2009
Human immunodeficiency virus type 1 is trapped by acidic but not by neutralized human cervicovaginal mucusSamuel K Lai, Kaoru Hida, Shetha Shukair, et al.
Journal of the American Academy of Dermatology|February 5, 2020
Bullous disorders associated with PD-1 and PD-L1 inhibitors: Pharmacovigilance analysis of the United States Food and Drug Administration Adverse Event Reporting System from the Research on Adverse Drug Events And Reports ProgramJavier Jimenez, Eran C Gwillim, Cory Kosche, et al.
Journal of Neurovirology|August 1, 2006
Transcriptional activity of blood-and cerebrospinal fluid-derived nef/long-terminal repeat sequences isolated from a slow progressor infected with nef-deleted human immunodeficiency virus type 1 (HIV-1) who developed HIV-associated dementiaMelissa J Churchill, Anna Figueiredo, Daniel Cowley, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Cell Host & Microbe|June 15, 2011
KAPs off for HIV-1 integrationAnna Figueiredo, Thomas J Hope
Current HIV Research|March 14, 2008
Impact of residues in the nonnucleoside reverse transcriptase inhibitor binding pocket on HIV-1 reverse transcriptase heterodimer stabilityAnna Figueiredo, Shannon Zelina, Nicolas Sluis-Cremer, et al.
Journal of Virology|December 14, 2007
Heat shock perturbs TRIM5alpha restriction of human immunodeficiency virus type 1Jenny L Anderson, Edward M Campbell, Anna Figueiredo, et al.
Plos Pathogens|November 14, 2006
Potent nonnucleoside reverse transcriptase inhibitors target HIV-1 Gag-PolAnna Figueiredo, Katie L Moore, Johnson Mak, et al.
Journal of Virology|August 21, 2009
Human immunodeficiency virus type 1 is trapped by acidic but not by neutralized human cervicovaginal mucusSamuel K Lai, Kaoru Hida, Shetha Shukair, et al.
Journal of the American Academy of Dermatology|February 5, 2020
Bullous disorders associated with PD-1 and PD-L1 inhibitors: Pharmacovigilance analysis of the United States Food and Drug Administration Adverse Event Reporting System from the Research on Adverse Drug Events And Reports ProgramJavier Jimenez, Eran C Gwillim, Cory Kosche, et al.
Journal of Neurovirology|August 1, 2006
Transcriptional activity of blood-and cerebrospinal fluid-derived nef/long-terminal repeat sequences isolated from a slow progressor infected with nef-deleted human immunodeficiency virus type 1 (HIV-1) who developed HIV-associated dementiaMelissa J Churchill, Anna Figueiredo, Daniel Cowley, et al.
Pageof 1